Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001777813-25-000003
Filing Date
2025-02-14
Accepted
2025-02-14 16:04:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 9187
  Complete submission text file 0001777813-25-000003.txt   10890
Mailing Address 2901 TASMAN DR. SUITE 205 SANTA CLARA CA 95054
Business Address 2901 TASMAN DR. SUITE 205 SANTA CLARA CA 95054 408-242-7319
Astera Labs, Inc. (Subject) CIK: 0001736297 (see all company filings)

EIN.: 823437062 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-94494 | Film No.: 25628210
SIC: 3674 Semiconductors & Related Devices
(CF Office: 04 Manufacturing)

Mailing Address ONE INTERNATIONAL PLACE SUITE 4410 BOSTON MA 02110
Business Address ONE INTERNATIONAL PLACE SUITE 4410 BOSTON MA 02110 6176484842
Atreides Management, LP (Filed by) CIK: 0001777813 (see all company filings)

EIN.: 833130520 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A